Insider: Polymeropoulos Mihael Hristos President and CEO - Vanda Pharmaceuticals Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 2,335,731 | 0 | 2,335,731 |
| Value | $11,912,228.10 | $0.00 | $11,912,228.10 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/07/2025 | AAP | 10,000 | Direct | COM | $4.15 | $41,500.00 | 2,335,731 |
| 05/21/2025 | AAP | 9,519 | Direct | COM | $4.40 | $41,883.60 | 2,325,250 |
| 05/21/2025 | AAP | 481 | Direct | COM | $4.39 | $2,111.59 | 2,325,731 |
| 05/16/2025 | AAP | 20,000 | Direct | COM | $4.22 | $84,472.00 | 2,315,731 |
| 03/06/2025 | AAP | 5,000 | Direct | COM | $5.02 | $25,100.00 | 2,290,731 |
| 03/06/2025 | AAP | 5,000 | Direct | COM | $5.01 | $25,050.00 | 2,295,731 |
| 03/05/2025 | AAP | 5,000 | Direct | COM | $5.01 | $25,050.00 | 2,280,731 |
| 03/05/2025 | AAP | 5,000 | Direct | COM | $5.03 | $25,150.00 | 2,285,731 |
| 03/03/2025 | AAP | 10,000 | Direct | COM | $4.71 | $47,050.00 | 2,275,731 |
| 02/26/2025 | AAP | 5,000 | Direct | COM | $4.78 | $23,900.00 | 2,341,730 |
| 02/26/2025 | AAP | 5,000 | Direct | COM | $4.75 | $23,750.00 | 2,336,730 |
| 02/25/2025 | AAP | 10,000 | Direct | COM | $4.46 | $44,640.00 | 2,331,730 |
| 03/05/2024 | DDS | 24,288 | Direct | COM | $4.13 | $100,273.01 | 1,871,730 |
| 03/04/2024 | DDS | 30,884 | Direct | COM | $4.24 | $131,065.52 | 1,896,018 |
| 03/03/2023 | DDS | 22,538 | Direct | COM | $6.25 | $140,876.02 | 1,476,902 |
| 03/02/2023 | DDS | 22,426 | Direct | COM | $6.23 | $139,718.47 | 1,499,440 |
| 12/06/2022 | DDS | 48,250 | Direct | COM | $10.61 | $512,082.08 | 1,406,866 |
| 12/05/2022 | DDS | 47,650 | Direct | COM | $10.62 | $506,200.25 | 1,379,751 |
| 03/02/2022 | DDS | 29,588 | Direct | COM | $11.15 | $329,944.66 | 1,352,766 |
| 03/01/2022 | DDS | 7,508 | Direct | COM | $11.19 | $84,014.52 | 1,382,354 |
| 12/01/2021 | DDS | 46,200 | Direct | COM | $16.00 | $739,347.84 | 1,274,862 |
| 11/30/2021 | DDS | 50,000 | Direct | COM | $16.49 | $824,275.00 | 1,249,386 |
| 03/08/2021 | DDS | 175,000 | Direct | COM | $18.00 | $3,150,052.50 | 1,221,062 |
| 03/02/2021 | DDS | 15,206 | Direct | COM | $18.34 | $278,902.37 | 1,396,062 |
| 03/01/2021 | DDS | 7,479 | Direct | COM | $18.45 | $138,002.51 | 1,411,268 |
| 1 2 3 4 5 Next Last You are at page 1 of 5 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research